News

Cancer Research5d
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
1Department of Radiation Oncology, Stanford University, Stanford, California. 2Stanford Cancer Institute, Stanford University, Stanford, California.
Cancer Research5d
Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant Mutations
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Cancer Research9d
Abstract CT185: Trispecific EGFR x cMET x VEGF antibody, TAVO412, has clinical responses in esophageal and lung cancers
Search for other works by this author on: ...
Cancer Research6d
Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth
1Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago, Chicago, Illinois. *Corresponding Author: Hilary A. Kenny, Department of Obstetrics and Gynecology, ...
Cancer Research5d
Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial
1Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain. 2Department of Basic Medical Sciences, Institute of Applied Molecular Medicine (IMMA), Facultad de Medicina, Universidad San Pablo ...
Cancer Research7d
A Guide to Extrachromosomal DNA: Cancer’s Dynamic Circular Genome
1Department of Pathology, Stanford University School of Medicine, Stanford, California.
Cancer Research13d
Abstract 410: The BTK degrader BGB-16673 shows anti-tumor activity in marginal zone lymphoma models
IOR - Institute of Oncology Research, Bellinzona, Switzerland.
Cancer Research9d
Abstract SY27-02: Exploring the significance of somatic mtDNA mutations in the context of acute leukemia
St. Jude Children's Research Hospital, Memphis, TN.
Cancer Research11d
Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia. *Corresponding Author: Priti Bandi, Risk Factors and Screening Research, Surveillance and Health Equity Science, ...
Cancer Research13d
Abstract 1591: Mechanisms of BPM31510-induced cell death in cancer: lipid peroxidation and apoptosis pathways
Search for other works by this author on: ...
Cancer Research7d
Pembrolizumab Boosts EFS in Head and Neck Cancer
According to data announced today at the American Association for Cancer Research Annual Meeting 2025, Merck’s anti-PD-1 mAb pembrolizumab (Keytruda) led to significant improvements in event-free ...
Cancer Research13d
Abstract 7427: Use of large language models for clinical data abstraction from oncologic medical records
Search for other works by this author on: ...